Eligibility criteria
The project must concern a biotherapy or bioproduction approach in health related to at least one of the following 3 thematic axes of the DIM BioConvS:
1) Life engineering and bioproduction
2) Development of therapeutic proofs of principle
3) New, high throughput and standardizable analytical methods
The team benefiting from the regional grant must be located in Île-de-France (without necessarily being part of the founding teams of the DIM).
The acquisition must take place within 18 months of the financing decision (i.e. no later than November 30, 2024).
The project submitted cannot be the subject of another subsidy from the Île-de-France Region. For any specific questions, contact the DIM BioConvS.
Collaborative or platform projects will be encouraged without however being mandatory.
Selection criteria
Apart from the scientific quality of the project, the evaluation will take into account the strategic nature of the equipment, its pooling and the involvement of young researchers and emerging teams.
List of documents that must be included in each file
- The completed form including administrative, financial, scientific and technical information (template to download in the left menu)
- The equipment quote
- The co-financing letter signed by the legal representative of the acquiring organization. If applicable, one letter must be provided for each co-funding organization.
Note: The co-financing letter must be signed by the legal representative of the acquiring organization. The laboratory director's signature will not be accepted.
Any incomplete file will not be evaluated.
Funding constraints
Teams benefiting from EQUIPEMENT 2023 support from DIM BioConvS will de facto be part of the DIM BioConvS network. Thus, the Île-de-France Region encourages its members to deposit their publications on open access platforms (HAL, etc.).
Depending on the means available, the scientific feasibility and with the agreement of the promoter, the DIM BioconvS reserves the right to finance only part of the project presented.
Please note that each grant beneficiary agrees to pay a cash advance:
- 80% of the grant will be paid to the beneficiary upon presentation of proof of payment;
- The remaining 20% will be paid to the beneficiary after the balance has been presented to the Region. The balance is presented to the Region once all grant recipients have justified their expenses.
Eligible Costs
Equipment whose total cost exceeds €7,500 excluding tax is eligible. Shipping, installation and training costs as well as maintenance may be eligible if this information appears clearly on the initial estimate and therefore if these services are supported directly by the supplier. Computers and software are also eligible if they are essential to the operation of the equipment.
It should be noted that no management fees may be deducted from the amount allocated for the acquisition of equipment by the managing establishments and/or beneficiaries and/or co-financiers of this subsidy.
All expenses are recorded net of tax.
Commitment
The beneficiary undertakes to cite the Île-de-France Region and the DIM BioConvergence pour la Santé in any publication where experiments have been carried out using the purchased equipment, adding the following wording to the acknowledgments section:
“This work has been supported by Region Ile-de-France in the framework of DIM BioConvS”
Obligations in terms of communication
The Region's logo must appear on all information and communication and/or event media relating to the supported project, whether printed, digital or audiovisual.
The visibility of the regional support will be done by the installation of stickers with only the logo of the Region. The stickers will be provided by the services of the Region.
Data management obligations
The beneficiary undertakes to comply with the General Data Protection Regulations (GDPR), i.e. all the rules relating to the protection of individuals with regard to the processing of personal data, to the free movement of such data and the right to the protection of such data. The Data Protection Officer (DPO) will provide you with best practices for data management.
